Effects of ibogaine on the development of tolerance to antinociceptive action of μ-, δ- and κ-opioid receptor agonists in mice

Brain Research

Volumn 752, Issue 1-2, 1997, Pages 250-254

  Cao, Ying Jun ^a   Bhargava, Hemendra N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

antinociception; DPDPE; ibogaine; morphine; mouse; opioid receptor agonist; tolerance; U 50,488H

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; IBOGAINE; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; OPIATE AGONIST;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; DRUG TOLERANCE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; IBOGAINE; MALE; MICE; MORPHINE; NARCOTICS; NOCICEPTORS; PYRROLIDINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU;

EID: 0030902679     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01470-9     Document Type: Article

References (26)

1. Bhargava, H.N., Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome and self-administrative behavior, Pharmacol. Rev., 46 (1994) 293-324.
2. Bhargava, H.N., Non-competitive antagonism of N-methyl-D-aspartate receptor inhibits tolerance to the analgesic action of U-50,488H. a κ-opiate receptor agonists in the rat. Gen. Pharmacol., 26 (1995) 1055-1060.
3. Bhargava, H.N., Gulati, A. and Ramarao, P., Effect of chronic administration of U-50,488H on tolerance to its pharmacological actions and on multiple opioid receptors in rat brain regions and spinal cord, J. Pharmacol. Exp. Ther., 251 (1989) 21-26.
4. Bhargava, H.N. and Matwyshyn, G.A., Dizocilpine (MK-801) blocks tolerance to the analgesic but not to the hyperthermic effect of morphine in the rat, Pharmacology, 47 (1993) 344-350.
5. 2-opioid receptor agonists in mice. Brain Res., 719 (1996) 56-61.
6. Cappendijk, S.L.T., Fekkes, D. and Dzoljic, M.R., The inhibitory effect of norharman on morphine withdrawal syndrome in rats: comparison with ibogaine, Behav. Brain Res., 65 (1994) 117-119.
7. Codd, E.E., High affinity ibogaine binding to a mu opioid agonist site. Life Sci., 57 (1995) PL 315-320.
8. D'Amour, F.E. and Smith, D.L. A method for determining loss of pain sensation, J. Pharmacol. Exp. Ther., 72 (1941) 74-79.
9. Deecher, D.C., Teitler, M., Soderlund, D.M., Boenmann, W.G., Kuekne, M.E. and Glick, S.D., Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies, Brain Res., 571 (1992) 242-247.
10. Dzoljic, E.D., Kaplan, C.D. and Dzoljic, M.R., Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats, Arch. Int. Pharmacodyn., 294 (1988) 64-70.
11. Frances, B., Gout, R., Cros, J. and Zajac, J.M., Effects of ibogaine on naloxone-precipitated withdrawal in morphine-dependent mice, Fund. Clin. Pharmacol., 6 (1992) 327-332.
12. Glick, S.D., Rossman, K., Rao, N.C., Maisonneuve, I.M. and Carlson, J.N., Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor, Neuropharmacology, 31 (1992) 497-500.
13. Glick, S.D., Rossman, K., Steindorf, S., Maisonneuve, I.M. and Carlson, J.M., Effects and after-effects of ibogaine on morphine self-administration in rats, Eur. J. Pharmacol., 195 (1991) 341-345.
14. Haley, T.J. and McCormick, W.G., Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse, Br. J. Pharmacol. Chemother., 12 (1957) 12-15.
15. Higgins, G.A., Nguyen, P. and Sellers, E.M., The NMDA antagonist dizocilpine (MK-801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal, Life Sci., 50 (1992) PL167-PL172.
16. Lotsof, H., Rapid method for interrupting the narcotic addition syndromes, U.S. Patent 4,499,096 (1985).
17. Maisonneuve, I.M., Keller, R.W. Jr. and Glick, S.D., Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study, Eur. J. Pharmacol., 199 (1991) 35-42.
18. Marquis, K., Peisla, M.J., Muth, F.A. and Boat, C.A., Effects of acute/chronic MK-801 on naloxone-precipitated jumping in morphine-dependent mice, Soc. Neurosci. Abstr., 17 (1991) 331.
19. Pearl, S.M., Davis, K.H., Teitler, M. and Glick, S.D., Radioligand-binding study of noribogaine, a likely metabolite of ibogaine, Brain Res., 675 (1995) 342-344.
20. 3H]MK-801 binding to the NMDA receptor complex. Psychopharmacology, 114 (1994) 672-674.
21. Popik, P., Layer, R.T., Fossom, L.H., Benveniste, M., Geter-Douglass, B., Witkin, J.M. and Skolnick., P., NMDA antagonist properties of the putative antiaddictive drug, ibogaine, J. Pharmacol. Exp. Ther., 275 (1995) 753-760.
22. Rasmussen, K., Fuller, R.W., Stockton, M.E., Perry, K.W., Swinford, R.M. and Ornstein, P.L., NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal, Eur. J. Pharmacol., 197 (1991) 9-16.
23. Sharpe, L.G. and Jaffee, J.H., Ibogaine fails to reduce naloxone-precipitated withdrawal in the morphine-dependent rat, NeuroReport, 1 (1990) 17-19.
24. Thorat, S.N., Veeranna, Reddy, P.L. and Bhargava, H.N., Biochemical and behavioral studies on the interaction between μ- and κ-opioid agonists in mice, Brain Res., 615 (1993) 191-198.
25. G-monomethyl-L-arginine and MK-801 on the abstinence syndrome in morphine-dependent mice, Brain Res., 642 (1994) 153-159.
26. 1-opioid receptor agonists, Peptides, 17 (1996) 233-236.